AGL 5.60 Decreased By ▼ -0.18 (-3.11%)
ANL 8.90 Increased By ▲ 0.02 (0.23%)
AVN 76.85 Decreased By ▼ -2.07 (-2.62%)
BOP 5.26 Decreased By ▼ -0.02 (-0.38%)
CNERGY 4.63 Decreased By ▼ -0.07 (-1.49%)
EFERT 81.27 Decreased By ▼ -0.33 (-0.4%)
EPCL 50.08 Decreased By ▼ -0.83 (-1.63%)
FCCL 13.16 Decreased By ▼ -0.22 (-1.64%)
FFL 5.69 Decreased By ▼ -0.03 (-0.52%)
FLYNG 7.07 Decreased By ▼ -0.08 (-1.12%)
FNEL 4.79 Decreased By ▼ -0.03 (-0.62%)
GGGL 8.80 Decreased By ▼ -0.10 (-1.12%)
GGL 14.55 Decreased By ▼ -1.33 (-8.38%)
HUMNL 5.69 Decreased By ▼ -0.08 (-1.39%)
KEL 2.63 Decreased By ▼ -0.03 (-1.13%)
LOTCHEM 28.60 Decreased By ▼ -0.45 (-1.55%)
MLCF 24.49 Decreased By ▼ -0.61 (-2.43%)
OGDC 72.43 Decreased By ▼ -0.02 (-0.03%)
PAEL 15.36 Increased By ▲ 0.01 (0.07%)
PIBTL 5.00 Decreased By ▼ -0.05 (-0.99%)
PRL 16.10 Decreased By ▼ -0.19 (-1.17%)
SILK 1.08 Decreased By ▼ -0.01 (-0.92%)
TELE 9.14 Decreased By ▼ -0.23 (-2.45%)
TPL 7.23 Decreased By ▼ -0.10 (-1.36%)
TPLP 18.61 Decreased By ▼ -0.34 (-1.79%)
TREET 21.68 Decreased By ▼ -0.32 (-1.45%)
TRG 136.71 Decreased By ▼ -4.44 (-3.15%)
UNITY 16.88 Decreased By ▼ -0.14 (-0.82%)
WAVES 9.86 Decreased By ▼ -0.04 (-0.4%)
WTL 1.41 No Change ▼ 0.00 (0%)
BR100 4,225 Decreased By -29.6 (-0.7%)
BR30 15,518 Decreased By -214.7 (-1.36%)
KSE100 42,150 Decreased By -243.4 (-0.57%)
KSE30 15,588 Decreased By -75.7 (-0.48%)
Follow us

ZURICH: Credit Suisse Vice Chair Severin Schwan faces opposition to his re-election to the board of the embattled Swiss lender, The Financial Times reported on Wednesday.

Some investors said they will try to block any move to extend the tenure of the Roche chief executive, who has been vice chair at Credit Suisse since April 2017.

The investors were not named by the paper, which said they belonged to the 10 biggest shareholders in Credit Suisse.

Having joined the bank's board in 2014, Schwan is also the lead independent director. During his stint, Credit Suisse's share price has slumped by 64% after it became embroiled in a string of scandals and losses.

Schwan had intended to leave before the bank's annual meeting in April, the newspaper said, citing three people familiar with the matter.

Credit Suisse flags 500mn Swiss franc legal hit to Q4

But he has been asked by other board members to reconsider his departure to maintain stability under the new chair, Axel Lehmann, who took charge last month following the abrupt departure of Antonio Horta-Osorio following breaches of coronavirus quarantine rules.

The FT said investors had serious concerns about Schwan's ability to lead pharmaceuticals and diagnostics group Roche while also acting as the bank's vice-chair.

"If he's up for election there will be a fight," one top 10 shareholder told the FT.

"His role as Roche CEO does not benefit Credit Suisse he should (leave Credit Suisse) and go on to another board," another top 10 shareholder told the newspaper.

The bank, which releases its annual results on Thursday, did not immediately respond to a request for comment. Neither did Roche.

Schwan is undecided whether he will stand for re-election at the bank's shareholder meeting in April 29, he told Swiss newspaper Tages-Anzeiger in January.

"In any case, the task now is to stabilise the bank, and I am happy to support the new chairman in this," he added.

Comments

Comments are closed.

Credit Suisse vice chair faces opposition to re-election

Rupee remains unchanged against US dollar

Giving the govt a chance, sit with us and call elections: Imran Khan

Oil ticks up ahead of OPEC+ meeting, EU Russian oil ban

PM Shehbaz condemns assassination attempt on Pakistani envoy in Kabul

OMCs take a hit as petroleum sales drop in Pakistan

India to continue buying Russian oil: ministry source

Imran Khan says Senator Azam Swati treated in 'vengeful manner'

Qurat ul Ain Fatima appointed new ECP spokesperson

OPEC set to stick or cut more amid plan to cap Russian oil price

Shafique and Haq give Pakistan solid start after England’s 657